Investigational Drug Information for PF-04991532
✉ Email this page to a colleague
What is the drug development status for PF-04991532?
PF-04991532 is an investigational drug.
There have been 9 clinical trials for PF-04991532.
The most recent clinical trial was a Phase 2 trial, which was initiated on June 1st 2011.
The most common disease conditions in clinical trials are Diabetes Mellitus, Type 2, Diabetes Mellitus, and Glucose Metabolism Disorders. The leading clinical trial sponsors are Pfizer and [disabled in preview].
Summary for PF-04991532
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 11 |
| WIPO Patent Applications | 4 |
| Japanese Patent Applications | 2 |
| Clinical Trial Progress | Phase 2 (2011-06-01) |
| Vendors | 20 |
Recent Clinical Trials for PF-04991532
| Title | Sponsor | Phase |
|---|---|---|
| A 2-week Trial Of PF-04991532 In Patients With Type 2 Diabetes | Pfizer | Phase 1 |
| Single Dose Study To Study The Absorption, Metabolism And Excretion Of PF-04991532 | Pfizer | Phase 1 |
| Study To Evaluate The Effect Of Renal Impairment On The Pharmacokinetics Of PF-04991532 | Pfizer | Phase 1 |
Clinical Trial Summary for PF-04991532
Top disease conditions for PF-04991532
Top clinical trial sponsors for PF-04991532
US Patents for PF-04991532
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
